Research Article
Antioxidant, Antibacterial, and Cytotoxic Activities of the Ethanolic Origanum vulgare Extract and Its Major Constituents
Table 2
Minimum Inhibitory Concentrations (MIC) of bacterial strains.
| Bacterial strains | Source | Ethanolic oregano extract (μg/mL) |
| Pseudomonas aeruginosa | | | 25619 | ATCC | 25 | Mucoid clinical isolate 1 | Cystic fibrosis isolate | 25 | Mucoid clinical isolate 2 | Cystic fibrosis isolate | 25 | Mucoid clinical isolate 3 | Cystic fibrosis isolate | 25 | Mucoid clinical isolate 4 | Cystic fibrosis isolate | 25 | Mucoid clinical isolate 5 | Cystic fibrosis isolate | 12.5 | Nonmucoid clinical isolate 1 | Cystic fibrosis isolate | 6.3 | Nonmucoid clinical isolate 2 | Cystic fibrosis isolate | 6.3 | Nonmucoid clinical isolate 3 | Cystic fibrosis isolate | 25 | Nonmucoid clinical isolate 4 | Cystic fibrosis isolate | 12.5 | Bordetella bronchiseptica | | | 10580 | ATCC | 12.5 | 4617 | ATCC | 12.5 | Escherichia coli | | | 25922 | ATCC | 25 | 700973 | ATCC | 12.5 | Burkholderia cenocepacia | | | 25608 | ATCC | 25 | Clinical isolate 1 | Cystic fibrosis isolate | 12.5 | Clinical isolate 2 | Cystic fibrosis isolate | 6.3 | Clinical isolate 3 | Cystic fibrosis isolate | 12.5 | Clinical isolate 4 | Cystic fibrosis isolate | 12.5 | Acinetobacter lwoffii 17925 | ATCC | 12.5 | Acinetobacter baumannii 19606 | ATCC | 12.5 | Moraxella catarrhalis 8176 | ATCC | 12.5 | Bacillus subtilis 6633 | ATCC | 6.3 | Staphylococcus aureus | | | 29213 | ATCC | 25 | Clinical isolate 1 | Cystic fibrosis isolate | 12.5 | Clinical isolate 2 | Cystic fibrosis isolate | 25 |
|
|